Question 1

How many shares of CPRX does ProShare Advisors LLC own?

Accepted Answer

As of 2026-Q2, ProShare Advisors LLC holds 28,649 shares of CPRX (CATALYST PHARMACEUTICALS INC).

Question 2

What is ProShare Advisors LLC's CPRX position worth?

Accepted Answer

As of 2026-Q2, ProShare Advisors LLC's CPRX position is worth $900,439.

Question 3

Is ProShare Advisors LLC buying or selling CPRX?

Accepted Answer

In 2026-Q2, ProShare Advisors LLC increased their CPRX position (+59.1% change in shares).

Question 4

When did ProShare Advisors LLC first buy CPRX?

Accepted Answer

Based on available 13F filings, ProShare Advisors LLC first reported a position in CPRX in 2024-Q3. They have held the position across 31 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	28,649	+59.1%	$900,439	0.0%	$31.43	36
2026-Q1	Decreased	18,010	-19.9%	$445,927	0.0%	$23.92	0
2025-Q4	Increased	22,499	+3.2%	$525,127	0.0%	$23.29	25
2025-Q3	Decreased	21,797	-15.6%	$429,401	0.0%	$19.55	0
2025-Q2	Decreased	25,821	-2.9%	$560,316	0.0%	$21.78	0
2025-Q1	Decreased	26,593	-21.1%	$644,882	0.0%	$24.69	0
2024-Q4	Increased	33,699	+44.5%	$703,297	0.0%	$21.07	33
2024-Q3	Increased	23,320	+35.9%	$463,601	0.0%	$19.56	31